Department of Family and Community Medicine, ChristianaCare Health Services, Inc., Wilmington, DE, USA.
Institute for Research in Equity and Community Health (iREACH), ChristianaCare Health Services, Inc., Wilmington, DE, USA.
J Med Screen. 2024 Sep;31(3):150-156. doi: 10.1177/09691413231213495. Epub 2023 Nov 21.
Lung cancer screening rates are very low despite a level B recommendation from the United States Preventive Services Task Force since 2013 and clear evidence that lung cancer screening reduces mortality. The Center for Medicare and Medicaid Services requires shared decision-making (SDM) for lung cancer screening reimbursement. The objective of this study was to determine the effect of an SDM intervention on lung cancer screening in primary care.
The study design was a single-arm clinical trial design. The intervention included phone contact outside of a primary care visit and the use of the Decision Counseling Program ®, an online interactive decision aid focused on determining the factors which influence patients to screen or not screen, prioritizing those factors, and determining a decision preference score. The primary outcome was the completion of low-dose computed tomography scan (LDCT) 1 year after the SDM session compared in participants versus nonparticipants.
From six practices, there were 1359 potentially eligible patients in electronic medical record data, and 336 were reached to assess eligibility criteria. A total of 80 patients consented to be in the study, 64 completed a decision counseling session and 16 did not complete a session. Among the 64 people who agreed to have decision counseling, 45% had LDCT, higher than typically seen in routine clinical practice. Although not a comparable group, among the 16 people who declined decision counseling, none had LDCT.
Decision counseling is a promising intervention that might support SDM in the context of improving uptake of lung cancer screening in primary care. However, further, larger studies are needed.
尽管美国预防服务工作组自 2013 年以来提出了 B 级推荐,并且有明确的证据表明肺癌筛查可以降低死亡率,但肺癌筛查的比例仍然很低。医疗保险和医疗补助服务中心要求肺癌筛查报销采用共同决策(SDM)。本研究的目的是确定 SDM 干预对初级保健中肺癌筛查的影响。
研究设计为单臂临床试验设计。干预措施包括初级保健就诊之外的电话联系和使用决策咨询计划(Decision Counseling Program®),这是一种在线互动决策辅助工具,侧重于确定影响患者进行或不进行筛查的因素,对这些因素进行优先级排序,并确定决策偏好评分。主要结果是在 SDM 会议后 1 年完成低剂量计算机断层扫描(LDCT),比较参与者与非参与者的完成情况。
在六个实践中,电子病历数据中有 1359 名潜在合格患者,对 336 名患者进行了评估以确定资格标准。共有 80 名患者同意参加研究,其中 64 名完成了决策咨询会议,16 名未完成会议。在同意进行决策咨询的 64 人中,45%接受了 LDCT,高于常规临床实践中的通常水平。尽管不是可比组,但在拒绝决策咨询的 16 人中,没有人进行 LDCT。
决策咨询是一种很有前途的干预措施,可能有助于在提高初级保健中肺癌筛查的接受率方面支持 SDM。然而,还需要进一步的、更大规模的研究。